至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Vav1-dependent Rac1 activation mediates hypoxia-induced gemcitabine resistance in pancreatic ductal adenocarcinoma cells through upregulation of HIF-1α expression

Cell Biol Int. 2023-08; 
Congyuan Zhu, Hao Hu, Ye Ma, Shuming Xiong, Dongming Zhu
Products/Services Used Details Operation
Molecular Biology Reagents … The Rac1T17N cDNA was amplified from the plasmid pEGFP-C2-T17NRac1 (GenScript) and subcloned into pcDNA3.1-HA (GenScript) using restriction enzymes Nhe I and Bam HI. … Get A Quote

摘要

Hypoxia has been shown to induce gemcitabine (GEM) resistance in pancreatic ductal adenocarcinoma (PDAC) cells, however, the underlying mechanisms remain to be clarified. In the present study, we investigated whether activation of Vav1/Rac1/HIF-1α axis is responsible for hypoxia-induced GEM resistance in PDAC cells. Our results showed that Rac1 activation contributed to hypoxia-induced GEM resistance in PANC-1 cells. Hypoxia treatment led to an increased expression level of Vav1, which was responsible for Rac1 activation and GEM resistance in PDAC cells. Furthermore, Rac1 mediated hypoxia-induced GEM resistance by upregulating HIF-1α in PDAC cells. Taken together, these findings suggest that hypoxia induces G... More

关键词

Rac1, Vav1, apoptosis, drug resistance, hypoxia, pancreatic ductal adenocarcinoma